These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885 [TBL] [Abstract][Full Text] [Related]
63. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM. Arnold A Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056 [TBL] [Abstract][Full Text] [Related]
64. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13. Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084 [TBL] [Abstract][Full Text] [Related]
65. The MENX syndrome and p27: relationships with multiple endocrine neoplasia. Molatore S; Pellegata NS Prog Brain Res; 2010; 182():295-320. PubMed ID: 20541671 [TBL] [Abstract][Full Text] [Related]
66. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822 [TBL] [Abstract][Full Text] [Related]
69. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours. Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646 [TBL] [Abstract][Full Text] [Related]
70. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia. Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118 [TBL] [Abstract][Full Text] [Related]
71. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020 [TBL] [Abstract][Full Text] [Related]
72. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations. Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291 [TBL] [Abstract][Full Text] [Related]
73. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1. Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V; J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098 [TBL] [Abstract][Full Text] [Related]
74. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600 [TBL] [Abstract][Full Text] [Related]
76. Genetic defects associated with familial and sporadic hyperparathyroidism. Hendy GN; Cole DE Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676 [TBL] [Abstract][Full Text] [Related]
77. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500 [TBL] [Abstract][Full Text] [Related]
78. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients. Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907 [TBL] [Abstract][Full Text] [Related]
79. Germline CDKN1B variant type and site are associated with phenotype in MEN4. Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846 [TBL] [Abstract][Full Text] [Related]
80. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]